We are a Netherlands-based boutique built around a simple idea: in biotech, the right partnership often decides whether strong science reaches patients, and most leadership teams don't have the time to drive that work themselves.
Tijd is Dutch for time. Our logo is a stylised clock, a quiet reminder of the only resource biotech leadership cannot create more of.
Strategic partnering is the discipline that often decides whether an asset reaches patients. It is also, predictably, the first thing that slips when day-to-day operations take over. Funding rounds, board prep, regulatory work, hiring, they all push partnering down the priority list, week after week, until the moment to act has passed.
We were built to fix that. To be your time partner, so the conversations that matter most for your company's future don't wait for a quieter week that never comes.
We are a tight team of senior partners. The partner who answers your first email is the same one who walks into the negotiation room. No associates between you and the conversation that matters.
Simon specialises in strategic development and deal negotiation, with a track record built across C-suite roles life-sciences consultancy. He has guided BD conversations across discovery, clinical-stage, and late-stage assets, ranging across the full deal spectrum from research collaborations to nine-figure transactions.
He believes in working hand-in-hand with clients, creating value-driven strategies that lead to shared success and sustainable growth. This vision is embedded in TYD Partners’ approach, driving long-term business development and growth for clients.
Marjolein leads strategic marketing and global business development at TYD. Her background in strategic and neuro-marketing gives her a disciplined approach to how an asset is positioned, who it should be positioned to, and how the partnering narrative is sequenced.
She built her career at the intersection of B2B strategy, brand, and commercial growth. With this, she brings an audience-first thinking of strong marketing, applied to the deal-making conversation. The result is sharper messaging, more relevant outreach, and a faster path from first call to signed term sheet.
Marjolein leads the firm's positioning work, partner-mapping, and ongoing market intelligence.
Sander joined TYD as a Partner after serving as Operations Manager at an European life science consultancy, where he advised global biotech and pharma on strategy and deal negotiations across all therapeutic areas and development stages.
With hands-on experience spanning early discovery through late-stage and commercialisation deals, he helps biotechs translate complex scientific and strategic narratives into clear, value-driven propositions and compelling BD materials.
Sander holds an MSc in Strategic Management and supports clients end-to-end, with a focus on long-term value creation.
Pim is a Partner at TYD, working with biotech and pharmaceutical companies to drive high-impact partnering and transaction outcomes. He combines hands-on deal experience with a global perspective gained from working across Asia and within the Dutch Ministry of Health.
This breadth enables him to navigate complex cultural, regulatory, and stakeholder environments with confidence. Prior to TYD Partners, Pim served in a C-suite role at a European consultancy, where he led strategic growth initiatives, prepared organisations for transactions, and delivered multiple successful deals.
He holds an MSc in Strategic Management and helps clients build pragmatic partnering strategies that accelerate growth and create sustainable, long-term value.
We chose the boutique shape deliberately. Six principles drive every engagement, and explain why our clients keep us close to the conversations they care about most.
The partner who answers your first email is the same one who closes the deal. No associates between you and management.
We work as part of your team, executing business development activities on your behalf, assisting with your board call preparations, and preserving long-term value for your shareholders.
You see every conversation in our shared tracking system in real time. With timely touching points, we stay closely aligned throughout our collaboration.
What we hear from the market each week reshapes positioning, messaging, and target list. This keeps the process agile and up to date.
Our engagement structures combine retainer and success-fee components, designed so we only win when you do too.
We take on a small number of engagements at a time to ensure we are staying focussed on your project.